Search clinical trials for: Tyrosine kinase inhibitor
Total 64889 results
-
Massachusetts General HospitalActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)Terminated
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Cutaneous MelanomaUnited States
-
National Cancer Center, ChinaNot yet recruiting
-
Medical College of WisconsinNot yet recruitingFollicular Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma
-
AstraZenecaRecruitingStage II-IIIB Non-small Cell Lung CarcinomaSpain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
-
Hyo Song KimCompletedDesmoid TumorKorea, Republic of
-
National Cancer Institute (NCI)CompletedLung Neoplasms | Lung AdenocarcinomaUnited States
-
Jennifer R. Brown, MD, PhDAstraZeneca; TG Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
Inhye AhnLoxo Oncology, Inc.RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsNot yet recruitingAcute Lymphoblastic Leukemia | Philadelphia Chromosome-PositiveUnited States
-
The First Affiliated Hospital with Nanjing Medical...AstraZenecaRecruitingChronic Lymphocytic LeukemiaChina
-
BeiGeneRecruitingRelapsed Diffuse Large B-cell Lymphoma | Refractory Diffuse Large B-cell LymphomaChina
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Italy, Spain, United Kingdom, Belgium, Denmark, Hungary, Poland, Australia, Germany, Israel, Netherlands, Turkey, France, New Zealand
-
University of Maryland, BaltimoreActive, not recruiting
-
AstraZenecaActive, not recruitingChronic Lymphocytic Leukemia or Small Lymphocytic LymphomaSpain, United States, Australia, France, Czechia, Hungary, Poland
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingLeukemia | Chronic Lymphocytic Leukemia | Relapsed/Refractory Chronic Lymphocytic LeukemiaSwitzerland
-
AstraZenecaParexelActive, not recruitingAdvanced Haematological MalignanciesSpain, United States, Canada, Korea, Republic of, Poland, Australia, France, United Kingdom, Ireland
-
Taizhou HospitalNot yet recruitingLung Cancer, Nonsmall Cell
-
M.D. Anderson Cancer CenterRecruitingLeukemia | Acute Lymphoblastic LeukemiaUnited States
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerUnited States, Korea, Republic of, Belgium, Canada, Australia, Brazil, China, Japan, Taiwan, Israel, France, Singapore, Germany, Spain, Thailand, Italy, Sweden, Turkey, Colombia, Costa Rica, Hong Kong, Poland, Chile, United Kingdom, New... and more
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Vanderbilt-Ingram Cancer CenterTerminatedRecurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingGIST and CMLChina, Finland, Turkey, Singapore, France, Switzerland, Thailand, Romania, Hong Kong, United Kingdom, United States
-
BeiGeneCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaPoland
-
Advanz PharmaAMS Advanced Medical Services GmbH; APCER Life SciencesCompletedHepatic Insufficiency | Renal Insufficiency | ImmunosuppressionSpain, France, Germany, Italy
-
Alliance Foundation Trials, LLC.PfizerActive, not recruitingB Cell Lymphoma | Mantle Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterWithdrawn
-
Polish Lymphoma Research GroupAstraZenecaActive, not recruitingMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Adverse Event | Chronic Graft-versus-host-disease | Response RatePoland
-
Centre Leon BerardActive, not recruitingPhiladelphia Chromosome Positive CML | BCR-ABL Positive Chronic Myelogenous LeukemiaFrance
-
National Cancer Institute (NCI)Not yet recruiting
-
AstraZenecaParexelRecruitingNon-Small Cell Lung Cancer (NSCLC)Korea, Republic of, Malaysia, Taiwan, Thailand, Hong Kong, Singapore, Canada
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
Nancy Lin, MDGlaxoSmithKline; NovartisActive, not recruitingBreast CancerUnited States
-
Assiut UniversityActive, not recruitingPatients Diagnosed as Chronic Meyloid LeukemiaEgypt
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
BayerCompleted
-
Milton S. Hershey Medical CenterTerminatedChronic Myeloid Leukemia, Chronic PhaseUnited States
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Georgetown UniversityAbbVie; Pharmacyclics LLC.; Hackensack Meridian HealthActive, not recruitingRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Philadelphia Chromosome | Mixed Phenotype Acute LeukemiaChina
-
AbbVieActive, not recruiting
-
University Health Network, TorontoNot yet recruiting
-
Janssen Research & Development, LLCPharmacyclics LLC.RecruitingLeukemia, Lymphocytic, Chronic, B-Cell | Small Lymphocytic LymphomaUnited States, Italy, Poland, Spain, Czechia
-
BeiGeneRecruitingWaldenstrom MacroglobulinemiaUnited States, Puerto Rico
-
M.D. Anderson Cancer CenterLoxo OncologyRecruitingMantle Cell Lymphoma | Non Hodgkin Lymphoma | Hematologic MalignancyUnited States
-
Johnson & Johnson Private LimitedCompletedLymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-CellIndia
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer (Stage III)United States, Spain, Taiwan, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Hungary, India, Japan, Mexico, Peru, Russian Federation, China, Malaysia, Argentina
-
Eli Lilly and CompanyActive, not recruitingNon Small Cell Lung CancerItaly, United States, Spain, Germany, Korea, Republic of, Poland, Romania, Taiwan, Ukraine, France, Japan, Russian Federation, Austria, Israel, Greece, Brazil, Argentina, Turkey, Canada, Puerto Rico, China